This approach has been design ed to provide adequate analgesia while minimizing exposure to adverse events
Background : Laparoscopic cholecystectomy has advantages over the open procedure for postoperative pain .
However , a systematic review of postoperative pain management in this procedure has not been conducted .
Intraperitoneal Bupivacaine Does Not Attenuate Pain Following Laparoscopic Cholecystectomy
Background : Laparoscopic cholecystectomy is characterized by a short hospital stay . Hence , pain control on the day of surgery is increasingly important . The aim of this study was to evaluate the effect of intraperitoneal bupivacaine on pain relief following laparoscopic cholecystectomy . Methods : Sixty patients undergoing elective laparoscopic cholecystectomy were prospect ively r and omized into 2 groups . Following removal of the gallbladder , group A received 100 mg of bupivacaine in 50 cc of saline , installed into the gallbladder bed and right subphrenic space . Group B received saline without bupivacaine .  Pain was assessed using a visual/analog scale at fixed-time intervals . Results : No significant difference occurred in the average pain levels between the groups at 1 , 2 , 4 , and 14 hours postsurgery . The average analgesic requirement was lower in the bupivacaine group , but this did not reach statistical significance . Conclusion : Application of intraperitoneal bupivacaine did not attenuate pain following laparoscopic cholecystectomy , and no role exists for its routine use
This approach has been design ed to provide adequate analgesia while minimizing exposure to adverse events
Background : Laparoscopic cholecystectomy has advantages over the open procedure for postoperative pain .
However , a systematic review of postoperative pain management in this procedure has not been conducted .